Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

NeoGenomics Inc (NEO) NPV

Sell:$25.25 Buy:$26.90 Change: $0.55 (2.11%)
NASDAQ:1.00%
Market closed |  Prices as at close on 6 December 2019 | Switch to live prices |
Sell:$25.25
Buy:$26.90
Change: $0.55 (2.11%)
Market closed |  Prices as at close on 6 December 2019 | Switch to live prices |
Sell:$25.25
Buy:$26.90
Change: $0.55 (2.11%)
Market closed |  Prices as at close on 6 December 2019 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

NeoGenomics, Inc. is an operator of a network of cancer-focused genetic testing laboratories. The Company operates in Laboratory Testing Segment. This segment delivers testing services to hospitals, pathologists, oncologists, other clinicians and researchers. It has laboratory locations in Ft. Myers and Tampa, Florida; Aliso Viejo, Fresno, Irvine, and West Sacramento, California; Houston, Texas and Nashville, and Tennessee. It offers testing services, which include Cytogenetics, Fluorescence In-Situ Hybridization (FISH), Flow cytometry, Immunohistochemistry (IHC), Molecular testing and Pathology consultation. Its Pharma Services and Clinical Trials group provides testing services in support of its pharmaceutical clients' oncology programs from discovery to commercialization. It helps its customers develop a biomarker hypothesis by recommending an optimal platform for molecular screening and backing its discovery tools with the informatics to capture meaningful data.

Contact details

Address:
12701 Commonwealth Dr Ste 9
FORT MYERS
33913-8626
United States
Telephone:
+1 (941) 9231949
Website:
https://neogenomics.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
NEO
ISIN:
US64049M2098
Market cap:
$2.71 billion
Shares in issue:
104.15 million
Sector:
Life Sciences Tools & Services
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Douglas VanOort
    Chairman of the Board, Chief Executive Officer
  • George Cardoza
    President - Pharma Services Division
  • Robert Shovlin
    President - Clinical Services Division
  • Kathryn McKenzie
    Principal Accounting Officer, Vice President - Finance
  • Steven Ross
    Chief Information Officer
  • John Park
    Chief Marketing Officer
  • Stephanie Bywater
    Chief Compliance Officer
  • William Bonello
    Chief Strategy and Corporate Development Officer, Director Investor Relations
  • Jennifer Balliet
    Chief Culture Officer
  • Lawrence Weiss
    Chief Medical Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.